Steven R. Schwid

2.4k total citations
23 papers, 1.6k citations indexed

About

Steven R. Schwid is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Steven R. Schwid has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 5 papers in Rheumatology. Recurrent topics in Steven R. Schwid's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Steven R. Schwid is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Steven R. Schwid collaborates with scholars based in United States, Canada and Denmark. Steven R. Schwid's co-authors include Robert H. Dworkin, Andrew Goodman, David N. Herrmann, Alec O'connor, John D. Markman, Peter Chang, Ron Cohen, Lauren Krupp, Andrew R. Blight and Theodore R. Brown and has published in prestigious journals such as The Lancet, Neurology and The Lancet Neurology.

In The Last Decade

Steven R. Schwid

20 papers receiving 1.5k citations

Peers

Steven R. Schwid
Steven R. Schwid
Citations per year, relative to Steven R. Schwid Steven R. Schwid (= 1×) peers Antonio Carotenuto

Countries citing papers authored by Steven R. Schwid

Since Specialization
Citations

This map shows the geographic impact of Steven R. Schwid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Schwid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Schwid more than expected).

Fields of papers citing papers by Steven R. Schwid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Schwid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Schwid. The network helps show where Steven R. Schwid may publish in the future.

Co-authorship network of co-authors of Steven R. Schwid

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Schwid. A scholar is included among the top collaborators of Steven R. Schwid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Schwid. Steven R. Schwid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwid, Steven R., David Oakes, Lynn M. Schuchter, et al.. (2010). Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Movement Disorders. 25(12). 1801–1808. 22 indexed citations
2.
Herrmann, David N., Alec O'connor, Steven R. Schwid, et al.. (2010). Broadening the spectrum of controls for skin biopsy in painful neuropathies. Muscle & Nerve. 42(3). 435–437. 5 indexed citations
3.
Marras, Connie, Anthony E. Lang, Shirley Eberly, et al.. (2009). A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Movement Disorders. 24(16). 2370–2378. 6 indexed citations
4.
Goodman, Andrew, Theodore R. Brown, Lauren Krupp, et al.. (2009). Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet. 373(9665). 732–738. 380 indexed citations
5.
Mehta, Lahar, Robert H. Dworkin, & Steven R. Schwid. (2009). Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Nature Clinical Practice Neurology. 5(2). 82–92. 52 indexed citations
6.
Mehta, Lahar, Michael McDermott, Andrew Goodman, & Steven R. Schwid. (2009). A randomized trial of memantine as treatment for spasticity in multiple sclerosis. Multiple Sclerosis Journal. 16(2). 248–251. 7 indexed citations
8.
White, William B., Phyllis Salzman, & Steven R. Schwid. (2008). Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease. Hypertension. 52(3). 587–593. 17 indexed citations
9.
Mehta, Lahar, et al.. (2008). Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Multiple Sclerosis Journal. 14(3). 425–427. 42 indexed citations
10.
O'connor, Alec, Steven R. Schwid, David N. Herrmann, John D. Markman, & Robert H. Dworkin. (2007). Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain. 137(1). 96–111. 355 indexed citations
11.
Ambrosio, Fabrisia, et al.. (2007). Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury. The Journal of Rehabilitation Research and Development. 44(5). 693–693. 15 indexed citations
12.
Schwid, Steven R., Andrew Goodman, Amy R. Weinstein, Michael McDermott, & Kenneth P. Johnson. (2007). Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial. Journal of the Neurological Sciences. 255(1-2). 57–63. 71 indexed citations
13.
Schwid, Steven R.. (2007). SYMPTOMATIC MANAGEMENT OF MULTIPLE SCLEROSIS. CONTINUUM Lifelong Learning in Neurology. 13(5). 181–197. 2 indexed citations
14.
Schwid, Steven R., William B. White, Karen Blindauer, et al.. (2006). Effects of tyramine administration in Parkinson's disease patients treated with selective MAO‐B inhibitor rasagiline. Movement Disorders. 21(10). 1716–1721. 60 indexed citations
15.
Schwid, Steven R. & Robert A. Gross. (2005). Bias, not conflict of interest, is the enemy. Neurology. 64(11). 1830–1831. 10 indexed citations
16.
Griggs, Robert C., et al.. (2005). Message from the Editors to our U.S. and International Reviewers. Neurology. 64(12). 1996–2000. 1 indexed citations
17.
Schwid, Steven R., John Thorpe, Mohammad K. Sharief, et al.. (2005). Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.. PubMed. 62(5). 785–92. 60 indexed citations
18.
Griggs, Robert C., Robert A. Gross, Richard J. Kryscio, Jonathan W. Mink, & Steven R. Schwid. (2004). Message from the Editors to our U.S. and International Reviewers. Neurology. 63(12). 2204–2208. 1 indexed citations
19.
Griggs, Robert C., et al.. (2003). Acknowledgment to Reviewers. Neurology. 61(12). 1640–1644. 1 indexed citations
20.
Cohen, Jeffrey A., et al.. (1999). Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders. Journal of Neuroimmunology. 98(1). 29–36. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026